ServiceNow (NOW) to Replace Celgene (CELG) in the S&P 500; Thermo Fisher Scientific (TMO) Set to Join S&P 100

Thermo Fisher Scientific Inc. (NYSE: TMO) will replace Celgene Corp. (NASDAQ: CELG) in the S&P 100, and ServiceNow Inc. (NYSE: NOW) will replace Celgene in the S&P 500 prior to the open of trading on Thursday, November 21. Bristol-Myers Squibb Co. (NYSE: BMY) is acquiring Celgene in a deal expected to be completed soon pending final conditions.

You May Also Be Interested In

• Guggenheim Downgrades ServiceNow (NOW) to Neutral, 'Great Run, But Valuation and Fundamentals Cap Near-term Upside'
• Sana Biotechnology (SANA) Announces Resignation of Douglas Williams
• 22nd Century Group (XXII) Announces Resignation of Sullivan and Mish from Board